Latest Breaking News On - Investors media - Page 1 : comparemela.com

PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023 at 2:30 p.m. ET. A live webcast of the event will be available on

University of pennsylvaniaUnited statesStuart hendersonMike beyerWilliam chouPassage bio incSam brown incHealthcare communicationsUniversity of pennsylvania gene therapy programAnnual inflammationImmunology conferencePassage bioGene therapy programBio investorsBio mediaChief executive officer